Valuation: Fisher & Paykel Healthcare Corporation Limited

Capitalization 2.1TCr 1.26TCr 1.07TCr 975.31Cr 933.7Cr 1.72TCr 1,14500Cr 1.79TCr 11TCr 4.51TCr 55TCr 4.74TCr 4.64TCr 1,94000Cr P/E ratio 2026 *
46.5x
P/E ratio 2027 * 39.9x
Enterprise value 2.07TCr 1.25TCr 1.06TCr 963.75Cr 922.64Cr 1.7TCr 1,13100Cr 1.77TCr 11TCr 4.45TCr 55TCr 4.68TCr 4.58TCr 1,91700Cr EV / Sales 2026 *
9.17x
EV / Sales 2027 * 8.18x
Free-Float
91.76%
Yield 2026 *
1.34%
Yield 2027 * 1.62%
1 day-2.51%
1 week-9.16%
Current month-8.30%
1 month-8.89%
3 months-5.33%
6 months-4.57%
Current year-5.48%
1 week 35.5
Extreme 35.5
40
1 month 35.5
Extreme 35.5
40.4
Current year 35.5
Extreme 35.5
40.4
1 year 31.8
Extreme 31.8
40.46
3 years 20.29
Extreme 20.29
40.46
5 years 18.02
Extreme 18.02
40.46
10 years 8.13
Extreme 8.13
40.46
Manager TitleAgeSince
Chief Executive Officer 65 01/04/2016
Director of Finance/CFO - 23/10/2018
Chief Operating Officer - 01/04/2024
Director TitleAgeSince
Director/Board Member 68 01/11/2001
Director/Board Member 65 01/04/2016
Chairman 67 28/08/2024
Change 5d. change 1-year change 3-years change Capi.($)
-2.51%-9.16%-0.28%+36.08% 1.3TCr
-0.41%-0.10%-13.83%+5.09% 20TCr
-2.48%-4.58%+12.43%+14.12% 13TCr
-0.21%-0.03%+49.06%+122.86% 7.02TCr
-0.04%+0.13%+42.33%+100.00% 6.04TCr
+0.29%+2.80%-21.61%-27.83% 5.01TCr
+2.04%+0.17% - - 3.71TCr
+0.20%+2.77%-22.63%-38.96% 2.69TCr
-0.32%+1.31%+12.84%+30.69% 2.44TCr
-0.26%-4.40%-18.19%-48.38% 1.97TCr
Average -0.37%-1.63%+4.46%+21.52% 6.25TCr
Weighted average by Cap. -0.60%-0.38%+5.33%+25.98%

Financials

2026 *2027 *
Net sales 225.82Cr 136.13Cr 115.1Cr 105.11Cr 100.63Cr 185.9Cr 12TCr 192.72Cr 1.23TCr 485.57Cr 5.95TCr 510.55Cr 500.01Cr 21TCr 251.8Cr 151.79Cr 128.34Cr 117.2Cr 112.2Cr 207.29Cr 14TCr 214.89Cr 1.37TCr 541.44Cr 6.64TCr 569.29Cr 557.54Cr 23TCr
Net income 45Cr 27Cr 23Cr 21Cr 20Cr 37Cr 2.47TCr 39Cr 245.49Cr 97Cr 1.19TCr 102.22Cr 100.11Cr 4.19TCr 53Cr 32Cr 27Cr 25Cr 23Cr 43Cr 2.88TCr 45Cr 285.84Cr 113.2Cr 1.39TCr 119.02Cr 116.56Cr 4.87TCr
Net Debt -25Cr -15Cr -13Cr -12Cr -11Cr -20Cr -1.36TCr -21Cr -134.85Cr -53Cr -654.57Cr -56Cr -55Cr -2.3TCr -37Cr -22Cr -19Cr -17Cr -16Cr -30Cr -2.01TCr -31Cr -199.41Cr -79Cr -967.95Cr -83Cr -81Cr -3.4TCr
Logo Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.
Employees
7,412
Date Price Change Volume
17/26/17 35.68 $ -2.51% 13,11,867
16/26/16 36.60 $ -0.03% 5,66,555
13/26/13 36.61 $ -7.08% 12,37,385
12/26/12 39.40 $ +0.13% 4,51,511
11/26/11 39.35 $ -1.58% 3,15,891
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
35.68NZD
Average target price
39.15NZD
Spread / Average Target
+9.73%

Quarterly revenue - Rate of surprise